Concord Medical Services Holdings Ltd
CCM NYSE· Services-Offices & Clinics Of Doctors Of Medicine
Last close · Oct 26, 2026
$3.90
KIRA · Stoqly’s AI analyst, in plain words
- Concord Medical Services Holdings Ltd had $64.1M of revenue in fiscal 2025, up 20.1% on the year before. Over five years, revenue changed +14.7% a year on average.
- Its operating margin was −56.8%, up 81.8 pts: of every 100 in sales, about −57 is left after running the business.
- Concord Medical Services Holdings Ltd lost $12.9M in fiscal 2025.
- Free cash flow was −$35.9M in fiscal 2025, −56.1% of revenue.
- Concord Medical Services Holdings Ltd owes $450M more than it holds in cash.
Market cap
$17.0M
P/E
—
Revenue
$64.1M
Net income
−$12.9M
Free cash flow
−$35.9M
Operating margin
−56.8%
Concord Medical Services Holdings Ltd in 30 seconds · fiscal 2025
Are sales growing?
+20.1%
Yes. Sales grew 20.1% last year.
Does it make a profit?
−20.2%
No. It lost money last year.
Does profit turn into cash?
−56.1%
No. It spent more cash than it brought in.
How healthy are the accounts?
6 / 9
Mixed. It passes 6 of 9 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Concord Medical Services Holdings Ltd does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 20-F · Apr 29, 2026
- Legal name
- Concord Medical Services Holdings Ltd
- CIK
- 0001472072
Concord Medical Services Holdings Ltd · CCM
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $75.3M | $70.1M | $75.9M | $53.4M | $64.1M |
| Revenue growth | 133.0% | −6.9% | 8.2% | −29.7% | 20.1% |
| Gross margin | −11.7% | −32.3% | −14.3% | −20.6% | 5.6% |
| Operating margin | −94.4% | −111.2% | −86.2% | −138.6% | −56.8% |
| Net income | −$42.1M | −$72.7M | −$42.0M | −$42.8M | −$12.9M |
| Net margin | −55.9% | −103.7% | −55.4% | −80.3% | −20.2% |
| Diluted EPS | −$29.12 | −$16.67 | −$9.62 | −$9.80 | −$2.96 |
| Cash | |||||
| Cash from operations | −$55.7M | −$32.2M | −$39.0M | −$55.3M | −$28.1M |
| Capital expenditure | $43.3M | $33.1M | $16.0M | $21.0M | $7.8M |
| Free cash flow | −$99.0M | −$65.3M | −$55.0M | −$76.2M | −$35.9M |
| FCF margin | −131.4% | −93.1% | −72.5% | −142.9% | −56.1% |
| Share count change | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Debt and strength | |||||
| Cash and short-term investments | $24.8M | $22.9M | $8.2M | $48.1M | $42.5M |
| Debt incl. finance leases | $390M | $433M | $427M | $511M | $492M |
| Loans, net | $26.6M | $42.6M | — | — | — |
| Shareholders' equity | −$216M | −$270M | −$299M | −$312M | −$300M |
| Current ratio | 0.7x | 0.7x | 0.3x | 0.5x | 0.5x |
| Interest coverage | −6.2x | −4.4x | −2.8x | −2.8x | −1.7x |
| Returns and quality | |||||
| Return on capital | −47.5% | −44.2% | −42.9% | −38.9% | −19.2% |
| Piotroski F-score | 3 | 3 | 5 | 3 | 6 |
| Altman Z'' | −2.8 | −3.5 | −4.7 | −4.2 | −4.0 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Concord Medical Services Holdings Ltd · CCM
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $3.90 a share, the company is worth $17.0M.
Source: SEC EDGAR XBRL filings (CIK 0001472072). Data updated October 24, 2026. Filed in CNY under US GAAP and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. For information only — not investment advice. Check the original filings before relying on any figure.